Siemens announces new immunoassay for Zika detection

Tuesday, Feb 07, 2017

Siemens Healthineers announced on Monday that its CE-marked immunoassay the Novagnost Zika Virus IgM µ-capture Assay is now commercially available to laboratories outside of the US.